Drug Patent Expirations in August 2009

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in August 2009


*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
BREATHTEK UBT FOR H-PYLORI Otsuka America urea, c-13 5,140,993 Aug 24, 2009
COMBIVIR Glaxosmithkline lamivudine; zidovudine 7,119,202 Aug 8, 2009
EPIVIR Glaxosmithkline lamivudine 7,119,202 Aug 8, 2009
EPIVIR-HBV Glaxosmithkline lamivudine 7,119,202 Aug 8, 2009
EPZICOM Smithkline Beecham abacavir sulfate; lamivudine 7,119,202 Aug 8, 2009
EVOXAC Daiichi Sankyo Co cevimeline hydrochloride 4,855,290 Aug 30, 2009
EXTRANEAL Baxter Hlthcare icodextrin 4,761,237 Aug 9, 2009
LOVAZA Smithkline Beecham omega-3-acid ethyl esters 5,698,594 Aug 4, 2009
MERETEK UBT KIT (W/ PRANACTIN) Otsuka America urea, c-13 5,140,993 Aug 24, 2009
RESTASIS Allergan cyclosporine 4,839,342 Aug 2, 2009
TRIZIVIR Glaxosmithkline abacavir sulfate; lamivudine; zidovudine 7,119,202 Aug 8, 2009
VFEND Pfizer voriconazole 5,116,844 Aug 11, 2009

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.


   No Comments yet


  1. Mohamed Fathi SAFFAR Pharm.D
      Aug 4, 2009

    GREETINGS
    I AM REALLY LUCKY TO FIND THIS SITE . PATENTS TOPIC IS HIGHLY USEFUL IN MY JOB TO PICK DRUG APPLICATIONS WHERE THE PATENT REGULATIONS ARE NOT OBSEVED. THIS DESPITE THE TRIPS REGULATIONS WHICH ARE GLOBAL .
    I THANK YOU FOR YOUR PRECIOUS HELP.YOU KNOW THAT IN THE FIELD OF DRUG REGISTRATION SHARING INTELLIGENCE AND HAVING THE RIGHT INFORMATION IS FUNDAMENTAL. AN APPLICATION WHERE THE IP REGULATIONS ARE NOT RESPECTED IS OBVIOUSLY NOT CONCERNED OF SAFETY QUALITY PURITY STABILITY OF THE API .

    SINCERE THANKS & WARM REGARDS

    MOHAMED FATHI SAFFAR Pharm.D
    VICE-DIRECTOR AT THE NATIONAL LAB FOR DRUG CONTROL .TUNIS .TUNISIA

  2. Alwal Reddy
      Sep 2, 2009

    wonderful info,

Leave a Reply